Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (291-300 of 369) with videos related to

Pageof 37
Sort By:
Human Pathology|August 7, 2004
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectivesDebra A Bell, Teri A Longacre, Jaime Prat, et al.
Retina (Philadelphia, Pa.)|December 13, 2005
Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2)Lars P J Cruysberg, Alan J Franklin, Jason Sanders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazoleY Wu, A J Palad, W J Wasilenko, et al.
The Journal of Pathology|April 30, 2009
Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasionJareer N Kassis, Victoria M Virador, Elizabeth A Guancial, et al.
Cancer Biology & Therapy|September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumorsNilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Cancer|January 22, 2010
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancerGisele A Sarosy, Mahrukh M Hussain, Michael V Seiden, et al.
Frontiers in Oncology|May 25, 2026
A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumorsAman Chauhan, Elise C Kohn, S Percy Ivy, et al.
Cancer Letters|November 3, 2010
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanismChiara Corrado, Stefania Raimondo, Anna Maria Flugy, et al.
British Journal of Clinical Pharmacology|March 12, 2011
Population pharmacokinetic analysis of sorafenib in patients with solid tumoursLokesh Jain, Sukyung Woo, Erin R Gardner, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)K J Luzzi, H J Varghese, I C MacDonald, et al.
Pageof 37

Showing results (291-300 of 369) with videos related to

Sort By:
Pageof 37
Human Pathology|August 7, 2004
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectivesDebra A Bell, Teri A Longacre, Jaime Prat, et al.
Retina (Philadelphia, Pa.)|December 13, 2005
Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2)Lars P J Cruysberg, Alan J Franklin, Jason Sanders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazoleY Wu, A J Palad, W J Wasilenko, et al.
The Journal of Pathology|April 30, 2009
Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasionJareer N Kassis, Victoria M Virador, Elizabeth A Guancial, et al.
Cancer Biology & Therapy|September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumorsNilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Cancer|January 22, 2010
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancerGisele A Sarosy, Mahrukh M Hussain, Michael V Seiden, et al.
Frontiers in Oncology|May 25, 2026
A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumorsAman Chauhan, Elise C Kohn, S Percy Ivy, et al.
Cancer Letters|November 3, 2010
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanismChiara Corrado, Stefania Raimondo, Anna Maria Flugy, et al.
British Journal of Clinical Pharmacology|March 12, 2011
Population pharmacokinetic analysis of sorafenib in patients with solid tumoursLokesh Jain, Sukyung Woo, Erin R Gardner, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)K J Luzzi, H J Varghese, I C MacDonald, et al.
Pageof 37